Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I guess the no orders cancelled bit could be read as "not orders cancelled YET" :)
I expect this to rally up from here to around 250/260 price which is where I would have thought it should have stopped.
Always a trader's dream and today is not different.
I dont disagree on the over reaction but I dont have strong support until circa 204 and the LOWEST analyst target is just under.
It may never that hit going forward (coming weeks) but im over cautious at present; I'd rather miss out than lose out
have added 10k shares so far - about 1/3 of what I hope to pick up as I leverage in for the dividend.
Q4 has never been a strog quarter for Spirent so the slowdown is disappointing but not surprising.
Update gives a mixed outlook "h2 weighted" but a 17% move down is a KNEE JERK reaction !
Spirent has much higher margin than the peer group, a strong structural positioning (5G/6G) but now trades at a deep discount at 16x. HUGE BUY
The yanks will trash this no doubt but LT is a buying opportunity in a dividend paying company.
Scarfell / Mark
I understand, however days like this present an opportunity for a quality company. The SP may well go to the years lows but I add and trim and having reduced my average to sub £1.01, over the years and trimmed at 283.12 276.04 287.02 I am only too delighted to reenter at these levels and rinse and repeat.
My 247 was, in hindsight too soon but will buy all the way down to 212 which i see as possible today.
Surprised at the drop, it wasn't a bad RNS. I was overviewing some of my portfolio looked at SPT and all signs are good for this year despite the global market problems. Can't remember who but they said it was a buy. Don't really have funds but would think even if I could scrape a few hundred quid it would be worth it.
Thoughts
Nothing to do with that its the heavier weighting on the unknown H2 2023
Understand why the share is down today - the update on slightly increased revenue is actual a fall after accounting for inflation - disappointing.
nice buy buy buy - such a bargain - topped up all the way down to 219.
Nothing to see here - a buying opportunity - having trimmed near the recent highs I am doubling at these levels and awaiting the enhanced dividend.
Sound share.
(Alliance News) - Spirent Communications PLC on Friday said it delivered a strong annual performance in 2022, but noted some hesitance among its clients for the first half of 2023.
In 2022, the provider of testing, analytics and security for telecommunications networks said its results were in line with expectations. Revenue is expected to come in at USD607 million, which is a 5.5% rise from USD576.0 million in 2021.
The Crawley, England-based company said it expects adjusted operating profit to come in slightly ahead of market consensus. According to estimates compiled by Spirent, consensus is for USD127 million, within a range of USD122 million to USD131 million. This would be up 7.2% from USD118.5 million in 2021.
However, Spirent noted that global economic conditions have caused some of its customers to delay their investment decisions in the new year.
Expecting great things with trading update expected to drop this week before y/e results.
Expected more sign order growth dividend increase, special perhaps and a relating to the £4+
In 2023.
Expected to be stellar.
Such a good news story here. One to watch.
DYOR
Expect this to go through £3 and beyond on stellar results and progressive dividend. IMHO a gem, to trade.
with a 71p average I hope to trade this down to zero average cost in 2023.
adding again at these levels. Next results will be mega - in and around 18th January.
Refreshing update as usual. Expect a nice dividend at y/e.
I have joined you on the basis of a predominance in buying today. This was a good share to buy, at the right time, in the past.
Just bought today - markets feel a lot better than the doom and gloom I had expected the last month
Such potential £5+ in time. One of my favourites.
DYOR
Results tomorrow let's hope this pushes through the £3 and holds.
Nice lift off the lows for those who stuck with it. Still trimming into the rises and buying on the dips.
Before the last results we were 220ish, all doom and gloom posters out in force. Nice move up to where we are today.
Good luck tomorrow.
M.
post on 28-03-22
In time £3, patience as usual but am adding at these breaks from my trimmed positions as per.
What crap is this:
"The Company confirms that following his participation in the Spirent US Employee Stock Purchase Plan ("US ESPP")and the completion of a 12 month savings period, Eric Updyke purchased 3,503 shares at a 15% discount to the market price on 29 April 2022."
Savings scheme or no savings scheme, freebies or discounted share purchases such as these should be banned.
Directors of companies are on good enough (too much) money to purchase their own company shares at full cost.
Would Eric Updyke have purchased these shares without the discount.
There is too much going on in a lot of companies where directors are just helping themselves, at the cost of the genuine shareholder.
Directors trading in their own companies' shares should be forbidden anyway.
" ..... discharging responsibility ....." my backside!
Strange trading pattern today 90% buys, mostly small automated trades and the SP drops like a stone
Very good update but distribution happening and no interest. Weak summer market likely and possible trouble in the autumn. Cash is king and the divi isn't even close to inflation.
Agreed, share price weakness just now is a good opportunity to average down. Growing market, strong order book, great cash generation and regular dividend. This will bounce back when the market begins to normalise. 211 is the 52 week low, i feel we might hit that before the bounce though.
Q1 trading statement due 06/05 . I can’t see anything but continued momentum. Very well run company